Company · CIK 0001341235 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Aldeyra Therapeutics, Inc. · ALDX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 PForm 4 → | Jun 5, 4:19 pm EDT | Todd C BradyPresident and CEO, Director | 250,000 | $1.67 | $418,450 | 1,721,298 | +17.0% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 AForm 4 → | Jun 11, 4:27 pm EDT | Nancy Miller-RichDirector | 73,318 | — | — | 3,318 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:26 pm EDT | Richard DouglasDirector | 92,232 | — | — | 2,323 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:25 pm EDT | Gary M. PhillipsDirector | 81,613 | — | — | 4,977 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:23 pm EDT | William D ClarkDirector | 72,323 | — | — | 2,323 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:21 pm EDT | Neal WalkerDirector | 73,318 | — | — | 3,318 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:20 pm EDT | Ben BronsteinDirector | 80,286 | — | — | 4,977 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:18 pm EDT | Darlene M Deptula-HicksDirector | 94,313 | — | — | 9,756 | — |